Asep Inc. is Granted Patent Approval for its Sepsis Diagnostic Technology in 13 European Countries and Australia by asepadmin | Nov 7, 2022 | Uncategorized
Asep Inc. Signs Agreement with Bohai Biomedical Technology Development Co., Ltd., to Establish the Feasibility of Peptide-based Oral Rinse for the Chinese Market by asepadmin | Oct 13, 2022 | Uncategorized
Asep Inc. Announces the Appointment of Jacqueline M. Tucker as CFO by asepadmin | Oct 5, 2022 | Uncategorized
Dr. Richard Heinzl, Physician, Humanitarian, Entrepreneur and Author Appointed to Asep Inc.’s Board of Directors by asepadmin | Oct 4, 2022 | Uncategorized
Pandemic Preparedness — Asep Inc. supports World Sepsis Day (September 13th) and announces the development of a test kit to identify severe sepsis, the leading cause of death and morbidity in pandemics by asepadmin | Sep 13, 2022 | Uncategorized
